5326485

Source:http://linkedlifedata.com/resource/pubmed/id/5326485

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030567, umls-concept:C0087111, umls-concept:C0220825, umls-concept:C1134436
pubmed:issue	5
pubmed:dateCreated	1966-7-23
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372546
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Parasympatholytics, http://linkedlifedata.com/resource/pubmed/chemical/Placebos
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0007-0947
pubmed:author	pubmed-author:StrangR RRR
pubmed:issnType	Print
pubmed:volume	20
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	249-51
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:5326485-Adult, pubmed-meshheading:5326485-Aged, pubmed-meshheading:5326485-Clinical Trials as Topic, pubmed-meshheading:5326485-Female, pubmed-meshheading:5326485-Humans, pubmed-meshheading:5326485-Male, pubmed-meshheading:5326485-Middle Aged, pubmed-meshheading:5326485-Muscles, pubmed-meshheading:5326485-Parasympatholytics, pubmed-meshheading:5326485-Parkinson Disease, pubmed-meshheading:5326485-Placebos
pubmed:year	1966
pubmed:articleTitle	A double-blind evaluation of lysivane in the treatment of Parkinson's disease.
pubmed:publicationType	Journal Article, Clinical Trial, Controlled Clinical Trial